Buscar
Teva Pharmaceutical Industries Ltd
TEVAAñadir a la lista de seguimiento
33.210USD
+1.010+3.14%
Cierre 06/23, 16:00（ET）Cotizaciones retrasadas 15 min
38.24BCap. mercado
26.97P/E TTM
Más Datos de Teva Pharmaceutical Industries Ltd Compañía
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Información de Teva Pharmaceutical Industries Ltd
Símbolo de cotizaciónTEVA
Nombre de la empresaTeva Pharmaceutical Industries Ltd
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Número de empleados33892
Tipo de seguridadDepository Receipt
Fin del año fiscalFeb 06
Dirección124 Dvora Hanevi'a St.
CiudadTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIsrael
Código postal6944020
Teléfono97239148213
Sitio Webhttps://www.tevapharm.com/
Símbolo de cotizaciónTEVA
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Ejecutivos de Teva Pharmaceutical Industries Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Teva Pharmaceutical Industries Ltd?
Los cinco principales accionistas de Teva Pharmaceutical Industries Ltd son: Prof. Varda Shalev
¿Cuántas instituciones poseen acciones de Teva Pharmaceutical Industries Ltd (TEVA)?
A fecha de 2026Q1, 1226 instituciones poseen acciones de Teva Pharmaceutical Industries Ltd, con un valor de mercado combinado de aproximadamente 725.07M, lo que representa el 62.27% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 9191465.00.
¿Cuál es la mayor fuente de ganancias de Teva Pharmaceutical Industries Ltd?
El 2026Q1, el segmento empresarial Generic products generó la ganancia más alta para Teva Pharmaceutical Industries Ltd, ascendiendo a 9.42B y representando el 54.59% de la ganancia total.
